The effect of semaglutide combined with metformin on liver inflammation and pancreatic beta-cell function in patients with type 2 diabetes and non-alcoholic fatty liver disease

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8efcd3e17a621761-LAX IP: 116.62.10.13 UTC time: 2024-12-10T11:17:17+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4